Participant Information Sheet/Consent Form. Norfolk & Norwich University Hospital NHS Foundation Trust. Marc Moncrieff

Size: px
Start display at page:

Download "Participant Information Sheet/Consent Form. Norfolk & Norwich University Hospital NHS Foundation Trust. Marc Moncrieff"

Transcription

1 Participant Information Sheet/Consent Form Norfolk & Norwich University Hospital NHS Foundation Trust Short Title The Melanoma Margins Trial (MelMarT) Title A Phase III, Multi-centre Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma Protocol Number ANZMTG Project Sponsor G Australia and New Zealand Melanoma Trials Group Coordinating Principal Investigator/ Principal Investigator Marc Moncrieff Part 1 What does my participation involve? 1 Introduction You are invited to take part in this research project, called the Melanoma Margins Trial (MelMarT). We are asking you if you would be prepared to take part because you have been diagnosed with a form of skin cancer called melanoma. Melanoma is a type of skin cancer that develops from melanocytes (pigment cells). The study aims to further medical knowledge and may improve future treatment of melanoma. The research project will investigate how much skin is necessary to remove around the melanoma when you have your wider excision surgery. Currently, doctors do not know how much skin is necessary to take away from around a melanoma to reduce the chances of it coming back and guidelines in different countries vary in their recommendations. This study will investigate if reducing the excision margin to 1cm is as good at reducing the risk of your melanoma returning as a 2cm excision margin. The study will involve ongoing follow up visits for 10 years after the surgery; however it is normal to be checked every year for 10 years once you have had the surgery to remove a melanoma. This Participant Information Sheet/Consent Form tells you about the research project. It explains the tests and treatments involved. Knowing what is involved will help you decide if you want to take part in the research. Please read this information carefully. It is important to ask questions about anything that you don t understand or want to know more about. Before deciding whether or not to take part, you might want to talk about it with a relative, friend, or your local doctor. Participation in this research is voluntary. If you don t wish to take part, you don t have to. You will receive the best possible care whether or not you take part. If you decide you want to take part in the research project, you will be asked to sign the consent section. By signing it you are telling us that you: Understand what you have read Consent to take part in the research project Consent to have the tests and treatments that are described Consent to the use of your personal and health information as described. You will be given a copy of this Participant Information and Consent Form to keep. Participant Information Consent Form MelMart Master V1.0 dated 18July2014 Page 1 of 9

2 2 What is the purpose of this research? The purpose of this study is to investigate if reducing the current standard 2cm excision margin to 1cm is safe and whether it may change the risk of your melanoma coming back. There is currently no good evidence to prove or disprove a 1cm margin is as safe as a 2cm margin and a clinical trial is the only way to investigate the safety of a 1cm margin and its possible benefits. The standard treatment for people with early melanoma is to remove it using surgery. This usually happens in 2 stages (described in Diagram 1 below). Step 1: The lesion is removed to confirm what it is (called a biopsy). This usually removes all of the lesion and leaves behind a scar Primary melanoma lesion 2 cm 1 cm Step 2: Once the lesion has been confirmed as melanoma, your doctor will discuss the MelMarT trial and if you consent and are randomised on to the trial, you will undergo a wider excision procedure. A wide margin of the skin surrounding the lesion is excised (either 1 cm or 2cm from the border of the lesion or from your biopsy scar). Diagram 1: Describes the surgical excisions when a melanoma is removed. In the first stage, a doctor, usually a dermatologist or skin specialist, removes some of the growth in order to evaluate the tissue and make a diagnosis. A pathologist examines the growth to confirm that it is a melanoma and to see if the entire tumour has been removed. You have already had this stage performed and it is most likely that there is only a scar left at the original site of your melanoma. The second stage, known as a wider excision, involves removing an extra safety margin of healthy skin surrounding the original melanoma site to ensure that any remaining scattered melanoma tumour cells are removed that may have been left behind after the first operation. This is done to reduce the chance of your melanoma returning. Depending on the country you are living in, current guidelines recommend a safety margin of between 1 and 3cm of healthy skin all around your melanoma is removed. Evidence from previous research suggests that a 1cm excision is enough to reduce a patient s risk of the melanoma coming back in the same area; however a trial is needed to prove this theory. Other advantages of a reduced surgical margin include: A smaller margin could mean less surgery which means a smaller scar and potentially less scar tissue. A smaller margin could mean that extra surgery to repair the wound, such as a skin graft or other reconstruction, is no longer necessary. A smaller margin could reduce the time it takes for patients to recover from their surgery, possibly resulting in a reduced stay in hospital post operatively. Less time in hospital may make it easier for patients to return to their normal routine as well as being more affordable overall. Reducing the pain that patients may feel immediately after their operation and in the longer term. Using a smaller margin may reduce the length of time it takes surgeons to perform the surgery, allowing them to see more patients in a day and increasing the availability of the surgeons so they can treat more people. Participant Information Consent Form MelMart Master V1.0 dated 18July2014 Page 2 of 9

3 This study will also look at the costs and effects of having surgery for both patients and the health system. In addition, this study will look at the financial impact of melanoma on patients households. By finding out if patients and their families are suffering from financial hardship, this information will help policy makers to address out-of-pocket costs for melanoma patients. 3. What does participation in this research involve? You will be participating in a randomised controlled clinical trial. Sometimes we do not know which treatment is best for treating a condition. To find out we need to compare different treatments. We put people into groups and give each group a different treatment. The results are compared to see if one is better. To try to make sure the groups are the same, each participant is put into a group by chance (random). In this way, we will be able to compare the results of the different margins and therefore determine which is the more effective in melanoma. This research project has been designed to make sure the researchers interpret the results in a fair and appropriate way and avoids study doctors or participants jumping to wrong conclusions. Randomisation means that you are put into a group by chance. Neither you nor your doctor can choose the group you will be in. In this study you will have a 50% chance of receiving 1cm or 2cm margin, much like if you flipped a coin. Screening: You will be asked to read though this form and be given the chance to ask questions and to sign to say you have understood. This process is known as informed consent. Once you have provided your informed consent, you will be asked to: Undergo a complete physical exam (Your physician will examine you and record your height, weight etc). Review your medical history with your treating physician. Have a photograph taken of the site of your primary melanoma lesion. Complete quality of life questionnaires (known as the FACT-M and EQ-5D-5L questionnaires). These questionnaires ask you how you feel about your treatment, disease and how it affects you and your daily life. Complete a pain assessment questionnaire (known as the PainDetect questionnaire). The questionnaires will take no longer than 30 minutes to complete in total and are multiple choice. Treatment: You will be assigned to receive either a: 1cm Wider Excision of your primary melanoma lesion 2cm Wider Excision of your primary melanoma lesion At the same time you will have a special test called a Sentinel Lymph Node Biopsy (SLNB). This is a staging procedure and your physician will discuss this with you further. Every patient will be offered this because it is a routine part of treatment and information about the SLNB result will also be collected by the trial team. There are no costs associated with participating in this research project, nor will you be paid. All medication, tests and medical care required as part of the research project will be provided to you free of charge. If you decide to participate in this research project, the study doctor will inform your local doctor. What do I have to do? For this trial you will be asked to attend regular visits with a doctor involved in this research. These visits are normal for patients with your condition; are recommended by your doctor and align with the national treatment guidelines. Participant Information Consent Form MelMart Master V1.0 dated 18July2014 Page 3 of 9

4 MelMarT Study Visit schedule: During the first Year (Year 1): You will attend the first study visit (called the baseline visit) and subsequently at visits performed at 3, 6 and 12 months (called follow up visits). During Years 2 to 10: Regular follow up visits will be performed, as part of the trial, once per year for up to 10 years; however it is normal to be checked at least every year for 10 years once you have had the surgery to remove a melanoma. There is no reason why you should not see your doctor more frequently if you need to. These follow-up visits are normal for patients with your condition; are recommended by your doctor and align with the national treatment guidelines. At all of these visits you will be asked to have a physical examination to check that your melanoma has not returned and to see if your health and skin has changed. At some of these visits, you will also be asked to fill out the same Quality Of Life questionnaires you completed at the start of the trial. Also, if you decide to participate in the MelMarT trial, your study doctor will inform your local doctor. X-Rays and Imaging: If, as part of your standard care, your physician would like you to have any of the following (including but not limited to), we would also like to ask for copies of the reports and images: X-Rays Computed Tomography Scans (CT) Magnetic resonance imaging (MRI) Positron emission tomography (PET) Ultrasound It is not required as part of this study that you have any of the above procedures, we only wish to collect copies if they form part of your routine care. 4. Other relevant information about the research project This research is an international study with many doctors coming together to share their findings. This research has been initiated by the lead study doctor, Dr Marc Moncrieff who is based at the Norfolk & Norwich University Hospital, in Norwich, England. This research is being conducted by the Australia and New Zealand Melanoma Trials Group (ANZMTG) in collaboration with Norwich Clinical Trials Unit, United Kingdom. ANZMTG does not make any profit from its work. It exists to further knowledge about melanoma, and works with doctors in other countries, including those based in Norwich. The first phase (pilot study) of this trial involves patients from a select number of hospitals. During this first phase, 400 people will take part in this study to determine if the project is feasible. The second phase (full study) will involve more countries and may include patients from the following countries: United Kingdom (UK) Sweden Poland Australia and New Zealand United States of America Netherlands Italy Brazil Canada Participant Information Consent Form MelMart Master V1.0 dated 18July2014 Page 4 of 9

5 All data gathered at any stage will help us make the right conclusions when it comes to the final analysis. If you consent to participate in the first phase; we will also use your data in the full study without needing to complete another form. A total of 10,000 people will take part in the second phase (full) study. This is a large trial which is why so many different countries, doctors, hospitals and people with melanoma are involved. Recruitment will take place over 5 years and those included will be followed up for a maximum of 10 years. Therefore the study will take 15 years to complete. 5. Do I have to take part in this research project? Participation in any research project is voluntary. If you do not wish to take part, you do not have to. If you decide to take part and later change your mind, you are free to withdraw from the project at any stage. Your decision whether to take part or not to take part, or to take part and then withdraw, will not affect your routine treatment, your relationship with those treating you, or your relationship with your institute [Norfolk & Norwich University Hospital NHS Foundation Trust]. If you decide to discontinue the study treatment, please notify a member of the research team beforehand. You will be asked to attend follow-up visits to allow collection of information regarding your health status. Alternatively, the investigator/sponsor will request your permission to access your medical records for collection of follow-up information for research and analysis. 6. What are the alternatives to participation? Surgery is considered standard of care treatment for people with this diagnosis however surgery can be performed outside the trial setting. This would mean you would undergo the standard 2 cm wide excision margin, or as determined by the treatment guidelines in your country. If you decide not to be part of the study you will be treated and followed up as per your local standard care guidelines. In most cases this is a 2cm surgical wide excision procedure. You will be followed up in the same way as you would if you were part of the study. Participation in this study is voluntary. If you choose not to participate in this study, you and your doctor can discuss and agree on the most appropriate treatment for your illness. Whatever your decision, it will not affect your relationship with the staff caring for you. If you wish to withdraw from the study once it has started, you can do so at any time. You do not have to give a reason. 7. What are the possible benefits of taking part? The results of the study may not directly benefit you. If you are allocated to the group receiving the 2cm excision then you will receive no direct benefit as this is the same as standard procedure. However you will contribute to research and the results may benefit those in the future with melanoma. Possible benefits if you are allocated to the 1cm margin include: Having less surgery to remove the primary melanoma lesion A smaller scar Less pain at the site of your surgery Reduced chance of requiring a skin graft to repair removed skin, which means a less complex procedure A shorter hospital stay post operatively A reduced time for recovery. This may have an implication on costs for yourself, your family, industry and the health system. We will ask you about the costs associated with your disease in order that we can help inform policy makers about the costs associated with treating melanoma. Participant Information Consent Form MelMart Master V1.0 dated 18July2014 Page 5 of 9

6 8. What are the possible risks and disadvantages of taking part? Surgery may cause side effects and all patients on the trial will undergo a wide excision. So irrespective of what treatment arm you are allocated to (1 or 2 cm excision margin) you may experience none, some or all of the effects listed below, and they may be mild, moderate or severe. If you have any of these side effects, or are worried about them, talk with your study doctor. Your study doctor will be looking out for side effects throughout the whole trial. Common Side Effects: Having a tissue sample taken may cause some discomfort, bruising, minor infection or bleeding (short term) Pain at surgical site (short and long term) Scarring at the surgical site (long term) Rare Side Effects: Reduced mobility in some locations on the body (face, hands areas surrounding joints etc) (short and long term) Infection at the surgical site (short term) Minor Bleeding (short term) Swelling at the site of surgery or in a limb (called lymphoedema) (long term) Reopening of the wound (short term) Tingling or numbness relating to damage to nerves (short and long term) Many side effects disappear shortly after the end of treatment. However, sometimes side effects can be serious, long lasting, or permanent. Your study doctor will discuss the best way of managing any side effects with you. There may be other side effects that the researchers do not expect or do not know about and that may be serious. Please tell your study doctor immediately if you experience any new or unusual symptoms. We believe that there will be no difference in the chance of the melanoma coming back between the patients that have a 2cm margin and those that have a 1cm. However it is possible that a 1cm margin is less effective and therefore you may be at an increased risk of your melanoma coming back. We do not know if this is the case and that is why we are conducting this study. There is a potential risk that the 1cm margin may not be wide enough for a small number of patients to completely remove all of the melanoma that can be seen under the microscope. The risk is very small but if this happens then you may need to have yet more surgery to ensure no melanoma has been left behind. This will be inconvenient and delay your recovery. We also believe that there is an increased risk of suffering any of the side-effects listed above for patients that have the bigger, 2cm margin, though this is standard treatment patients would normally be offered by their doctor for their melanoma. In order to manage this risk your doctor will be checking on you regularly as part of this study. 9. What if new information arises during this research project? Sometimes during the course of a research project, new information becomes available about the treatment that is being studied. If this happens, your study doctor will tell you about it and discuss with you whether you want to continue in the research project. If you decide to withdraw, your study doctor will make arrangements for your regular health care to continue. 10. Can I have other treatments during this research project? Yes, while you are participating in this research project, you are able to continue taking any of the medications or treatments you have been taking for your condition or for other reasons. Participant Information Consent Form MelMart Master V1.0 dated 18July2014 Page 6 of 9

7 However it is important to tell your study doctor and the study staff about any treatments or medications, including over-the-counter medications, vitamins, herbal remedies, acupuncture, or other alternative treatments. You should also tell your study doctor about any changes to these during your participation in the research project. Your study doctor should also explain to you which treatments or medications need to be stopped for the time you are involved in the research project. 11. What if I withdraw from this research project? If you decide to withdraw from the project, please notify a member of the research team before you withdraw. If you do withdraw your consent during the research project, the study doctor and relevant study staff will not collect additional personal information from you, although personal information already collected will be retained to ensure that the results of the research project can be measured properly and to comply with law. You should be aware that data collected by the sponsor up to the time you withdraw will form part of the research project results. If you do not want them to do this, you must tell them before you join the research project. 12. Could this research project be stopped unexpectedly? This research project may be stopped unexpectedly for a variety of reasons which will be reviewed by the trial management committee and your study doctor will be immediately notified of any decision to stop the trial; reasons may include: Feasibility and recruitment issues Unacceptable side effects The 1cm margin is shown not to be as safe as the 2cm margin 13. What happens when the research project ends? Once you have completed the study, the study team will collate and publish the results in the medical community in journals and conference presentations. The final published results will be shared with you by your study doctor, and publicly accessible for the benefit of all patients diagnosed with melanoma, doctors, and researchers. Furthermore, you will be followed up as per your local healthcare provider s standard of care. If your melanoma returns you will be offered the choice of the best treatment available by your treating doctor. Part 2 How is the research project being conducted? 14. What will happen to information about me? By signing the consent form, you consent to the study doctor and relevant research staff collecting and using personal information about you for the research project. Any information obtained in connection with this research project that can identify you will remain confidential. Your information will be non-identified and will not be linkable to yourself in any way. Your information will only be used for the purpose of this research project and it will only be disclosed with your permission, except as required by law. Information about you may be obtained from your health records held at this and other health services for the purpose of this research. By signing the consent form you agree to the study team accessing health records if they are relevant to your participation in this research project. Your health records and any information obtained during the research project are subject to inspection (for the purpose of verifying the procedures and the data) by the relevant regulatory authorities. By signing the Consent Form, you authorise release of, or access to, this confidential information to the relevant people working on this study, those to whom they report and the organisations over them. Participant Information Consent Form MelMart Master V1.0 dated 18July2014 Page 7 of 9

8 It is anticipated that the results of this research project will be published and/or presented in a variety of forums. In any publication and/or presentation, information will be provided in such a way that you cannot be identified, except with your permission. Information about your participation in this research project may be recorded in your health records. Any information obtained for the purpose of this research project and for the future research described in Section 16 that can identify you will be treated as confidential and securely stored. It will be disclosed only with your permission, or as required by law 15. Complaints and compensation You may have a right to take legal action to obtain compensation for any injuries or complications resulting from the study. Compensation may be available if your injury or complication is sufficiently serious and is caused by unsafe drugs or equipment, or by the negligence of one of the parties involved in the study (for example, the researcher, the hospital, or the treating doctor). By signing the consent form, you have not waived any legal or other right to seek compensation. 16. Who is organising and funding the research? This research is being organised and funded by ANZMTG and Norfolk & Norwich University Hospital. There is a local sponsor of this study in each participating country who is also responsible for organising and funding the research in your institution. No member of the research team will receive a personal financial benefit from your involvement in this research project (other than their ordinary wages). 17. Who has reviewed the research project? All research in the UK involving humans is reviewed by an independent group of people called a National Research Ethics Service Committee (NRES). The ethical aspects of this research project have been approved by the NRES of East of England. This project will be carried out according to the principles agreed at the International Conference on Harmonisation Good Clinical Practise. In the UK this is governed by Research Goverance Framework. 18. Further information and who to contact The person you may need to contact will depend on the nature of your query. If you want any further information concerning this project or if you have any medical problems which may be related to your involvement in the project (for example, any side effects), you can contact the principal study doctor, or clinical research nurse on or any of the following people: Clinical contact person Name Marc Moncrieff Position Consultant Plastic Surgeon Telephone Fax For matters relating to research at the site at which you are participating, the details of the local site complaints person are: Participant Information Consent Form MelMart Master V1.0 dated 18July2014 Page 8 of 9

9 Complaints contact person Name Patient Advice & Liaison Services Position Norfolk & Norwich University Hospital Telephone Website Participant Information Consent Form MelMart Master V1.0 dated 18July2014 Page 9 of 9

Malignant Melanoma. Cancer Services Information for patients

Malignant Melanoma. Cancer Services Information for patients Malignant Melanoma Cancer Services Information for patients i This information is for patients being treated within the Departments of Dermatology, Plastic Surgery and Oncology What is malignant melanoma?

More information

Patient Information Leaflet: Part 1 select-d

Patient Information Leaflet: Part 1 select-d Patient Information Leaflet: Part 1 select-d Anticoagulation Therapy in SELECTeD Cancer Patients at Risk of Recurrence of Venous Thromboembolism Introduction This

More information

Malignant Melanoma. Exceptional healthcare, personally delivered

Malignant Melanoma. Exceptional healthcare, personally delivered Malignant Melanoma Exceptional healthcare, personally delivered What is malignant melanoma?. Malignant melanoma is a form of skin cancer which can start in a pre-existing mole or normal looking skin. What

More information

UNDERSTANDING MELANOMA IN SITU AND LENTIGO MALIGNA

UNDERSTANDING MELANOMA IN SITU AND LENTIGO MALIGNA UNDERSTANDING MELANOMA IN SITU AND LENTIGO MALIGNA Patient Information Leaflet Your Health. Our Priority. Page 2 of 6 Introduction You have had melanoma in situ or lentigo maligna diagnosed. You may be

More information

Skin Cancer Services. Sentinel Lymph Node Biopsy for Skin Cancer. Patient Information Leaflet. Whiston Hospital. Warrington Road.

Skin Cancer Services. Sentinel Lymph Node Biopsy for Skin Cancer. Patient Information Leaflet. Whiston Hospital. Warrington Road. Continued from previous page. Dressing Clinic Level 3 Green Zone L35 5DR Tel: 0151 430 1520 Macmillan Cancer Support/Information Centre St Helens Hospital Lower Ground Floor Marshalls Cross Road St Helens

More information

CALGB A Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small ( 2 cm) Peripheral Non-Small Cell Lung Cancer

CALGB A Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small ( 2 cm) Peripheral Non-Small Cell Lung Cancer A Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small ( 2 cm) Peripheral Non-Small Cell Lung Cancer What is a research study or clinical trial? This is a clinical trial, a type

More information

Surgery for breast cancer in men

Surgery for breast cancer in men Surgery for breast cancer in men This information is an extract from the booklet Understanding breast cancer in men. You may find the full booklet helpful. We can send you a free copy see page 9. Contents

More information

HOW MANY PEOPLE WILL TAKE PART IN THE STUDY?

HOW MANY PEOPLE WILL TAKE PART IN THE STUDY? Department/Section of Obstetrics and Gynecology MULITCENTERED, RANDOMIZED CONTROLLED TRIAL OF SALPINGO(S)TOMY VERSUS SALPINGECTOMY FOR TUBAL PREGNANCY; THE IMPACT ON FUTURE FERTILITY Informed Consent Form

More information

Breast Cancer Diagnosis, Treatment and Follow-Up

Breast Cancer Diagnosis, Treatment and Follow-Up Breast Cancer Diagnosis, Treatment and Follow-Up What is Breast Cancer? Each of the body s organs, including the breast, is made up of many types of cells. Normally, healthy cells grow and divide only

More information

The RADICALS trial Radiotherapy Timing Randomisation (RADICALS-RT) Clinical trial of treatment after surgery for prostate cancer

The RADICALS trial Radiotherapy Timing Randomisation (RADICALS-RT) Clinical trial of treatment after surgery for prostate cancer Stoke Mandeville Hospital Mandeville Road Aylesbury Buckinghamshire HP21 8AL Tel: 01296 315 908 www.buckshealthcare.nhs.uk The RADICALS trial Radiotherapy Timing Randomisation (RADICALS-RT) Clinical trial

More information

Sentinel lymph node biopsy for melanoma

Sentinel lymph node biopsy for melanoma Sentinel lymph node biopsy for melanoma Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm

More information

AIR. Ankle Injury Rehabilitation. Chief Investigator: Dr Rebecca Kearney PATIENT INFORMATION SHEET

AIR. Ankle Injury Rehabilitation. Chief Investigator: Dr Rebecca Kearney PATIENT INFORMATION SHEET AIR Ankle Injury Rehabilitation Chief Investigator: Dr Rebecca Kearney PATIENT INFORMATION SHEET We would like to invite you to take part in our research study, investigating two different treatments for

More information

Micrographic (Mohs ) surgery to treat your skin cancer: Slow Mohs'

Micrographic (Mohs ) surgery to treat your skin cancer: Slow Mohs' Micrographic (Mohs ) surgery to treat your skin cancer: Slow Mohs' Your doctor has recommended micrographic surgery to remove your skin cancer. This leaflet explains what the procedure involves, as well

More information

Questions and answers on breast cancer Guideline 5. The management of ductal carcinoma in situ (DCIS) (revised Oct. 2, 2001)

Questions and answers on breast cancer Guideline 5. The management of ductal carcinoma in situ (DCIS) (revised Oct. 2, 2001) Questions and answers on breast cancer Guideline 5. The management of ductal carcinoma in situ (DCIS) (revised Oct. 2, 2001) What is DCIS? DCIS stands for ductal carcinoma in situ a kind of cancer that

More information

What is a sentinel lymph node biopsy? What is the lymphatic system?

What is a sentinel lymph node biopsy? What is the lymphatic system? Guy s, King s and St Thomas Cancer Centre The Cancer Outpatient Clinic Having a sentinel lymph node biopsy and wide local excision for malignant melanoma This information leaflet has been given to you

More information

Excision or Open Biopsy of a Breast Lump Your Operation Explained

Excision or Open Biopsy of a Breast Lump Your Operation Explained Excision or Open Biopsy of a Breast Lump Your Operation Explained Patient Information Introduction This leaflet tells you about the procedure known as excision or open biopsy of a breast lump. It explains

More information

100,000 Genomes Project West Midlands NHS Genomic Medicine Centre

100,000 Genomes Project West Midlands NHS Genomic Medicine Centre england 100,000 Genomes Project West Midlands NHS Genomic Medicine Centre not you want to take part. If you don t want to take part in this Project, you don t have to. You don t have to give a 1. INTRODUCTION

More information

Removing a kidney using singleincision

Removing a kidney using singleincision Issue date November 2011 Understanding NICE guidance Information for people who use NHS services Removing a kidney using singleincision keyhole surgery NICE interventional procedures guidance advises the

More information

Information Sheet and Consent Form

Information Sheet and Consent Form Principal Investigators: Sponsor: Queen s Perinatal Research Unit Information Sheet and Consent Form Folic Acid Clinical Trial (FACT) - Effect of folic acid supplementation in pregnancy on preeclampsia:

More information

Types of sarcoma surgery

Types of sarcoma surgery Useful information for cancer patients Contents This information is about different types of surgery for soft tissue sarcoma. There are sections on Types of operation for sarcoma Limb sparing surgery Amputation

More information

This information explains the advice about skin cancer (melanoma) that is set out in NICE guideline NG14.

This information explains the advice about skin cancer (melanoma) that is set out in NICE guideline NG14. Information for the public Published: 29 July 2015 nice.org.uk About this information NICE guidelines provide advice on the care and support that should be offered to people who use health and care services.

More information

UNIVERSITY OF PENNSYLVANIA

UNIVERSITY OF PENNSYLVANIA UNIVERSITY OF PENNSYLVANIA RESEARCH SUBJECT INFORMED CONSENT AND HIPAA AUTHORIZATION FORM Protocol Title: Principal Investigator: Emergency Contact: A Structural Approach to Bone Disease Due to Hepatitis

More information

PATIENT INFORMATION SHEET KEY FACTS

PATIENT INFORMATION SHEET KEY FACTS PATIENT INFORMATION SHEET KEY FACTS Please read this carefully and refer to the full information sheet You are invited to take part in a research study, comparing subcutaneously (injection under skin)

More information

Wire localisation Followed by surgical biopsy or wide local excision

Wire localisation Followed by surgical biopsy or wide local excision The Jane Ashley Centre Wire localisation Followed by surgical biopsy or wide local excision Information for patients page 1 Wire Localisation page 2 The aim of this booklet is to give you some general

More information

Add-Aspirin Clinical Trial We are inviting you to take part in a research study called the Add-Aspirin trial

Add-Aspirin Clinical Trial We are inviting you to take part in a research study called the Add-Aspirin trial (To be presented on local headed paper) Version 4.0, 11-Nov-2014 Add-Aspirin Clinical Trial We are inviting you to take part in a research study called the Add-Aspirin trial Before you decide whether to

More information

Lymph node removal for melanoma

Lymph node removal for melanoma Lymph node removal for melanoma This information is an extract from the booklet Understanding melanoma lymph node assessment and treatment, which is part of a series of booklets on melanoma. You may find

More information

PATIENT INFORMATION SHEET

PATIENT INFORMATION SHEET PATIENT INFORMATION SHEET Surgical and large bore pleural procedures in Malignant pleural Mesothelioma And Radiotherapy Trial (SMART trial) Stoke Mandeville Hospital Mandeville Road Aylesbury Buckinghamshire

More information

Information for. Patients with an Abnormal Lung X-Ray

Information for. Patients with an Abnormal Lung X-Ray Information for Patients with an Abnormal Lung X-Ray Some of the materials in this resource were adapted, with permission, from: Understanding Lung Cancer, Juravinski Cancer Centre, Hamilton Health Sciences,

More information

MELANOMA INSTITUTE AUSTRALIA SENTINEL NODE BIOPSY PROCEDURE

MELANOMA INSTITUTE AUSTRALIA SENTINEL NODE BIOPSY PROCEDURE MELANOMA INSTITUTE AUSTRALIA SENTINEL NODE BIOPSY PROCEDURE PATIENT INFORMATION WHAT IS SENTINEL NODE BIOPSY? Sentinel node biopsy is a procedure that provides very important information to help predict

More information

Information for patients having an operation to remove their lymph glands

Information for patients having an operation to remove their lymph glands Information for patients having an operation to remove their lymph glands Plastic Surgery Department This leaflet is for anyone having an operation to remove lymph glands. It should help you to understand

More information

Lymph node dissection

Lymph node dissection Lymph node dissection (of armpit or groin) Information for patients Dermatology page 2 of 12 Lymph node dissection You have been advised by your plastic surgeon to have a lymph node dissection. This leaflet

More information

U.K. Familial Ovarian Cancer Screening Study (UK FOCSS) Phase 2 Patient Information Sheet

U.K. Familial Ovarian Cancer Screening Study (UK FOCSS) Phase 2 Patient Information Sheet U.K. Familial Ovarian Cancer Screening Study (UK FOCSS) Phase 2 Patient Information Sheet 1. Invitation You are being invited to take part in a research study. Before you decide it is important for you

More information

PATIENT INFORMATION SHEET

PATIENT INFORMATION SHEET PATIENT INFORMATION SHEET This Patient Information Sheet is 5 pages long. Please make sure you have all the pages. If English is not your preferred language and you would like this information in another

More information

Diagnosis of melanoma

Diagnosis of melanoma This information is an extract from the booklet Understanding melanoma and treatment with surgery, which is part of a series of booklets on melanoma. You may find the full booklet helpful. We can send

More information

1. Study title Is the title self explanatory to a layperson? If not, a simplified title should be included.

1. Study title Is the title self explanatory to a layperson? If not, a simplified title should be included. These guidelines apply to all research projects where human subjects are involved in the study GUIDELINES FOR RESEARCHERS PATIENT INFORMATION SHEET & CONSENT FORM The guidance, which follows, applies primarily

More information

Squamous Cell Carcinoma

Squamous Cell Carcinoma Squamous Cell Carcinoma Patient Information What are the aims of this leaflet? This leaflet has been written to help you understand more about squamous cell carcinomas of the skin. It tells you what they

More information

Sentinel Lymph Node Biopsy Your Operation Explained

Sentinel Lymph Node Biopsy Your Operation Explained Sentinel Lymph Node Biopsy Your Operation Explained Patient Information Introduction This booklet is designed to give you information about having a sentinel node biopsy and the care you will receive before,

More information

Groin or inguinal lymph node dissection

Groin or inguinal lymph node dissection Department of plastic surgery Groin or inguinal lymph node dissection Groin lymph node dissection The surgery you are going to have is called groin or inguinal lymph node dissection. This means removing

More information

Couples Information Leaflet

Couples Information Leaflet Couples Information Leaflet This project was funded by the National Institute for Health Research, Health Technology Assessment Programme (project number 13/115/82) You are due to undergo in vitro fertilisation

More information

Treating melanoma with local surgery

Treating melanoma with local surgery Treating melanoma with local surgery This information is an extract from the booklet Understanding melanoma and treatment with surgery, which is part of a series of booklets on melanoma. You may find the

More information

INSTITUTION HEADED PAPER

INSTITUTION HEADED PAPER PATIENT INFORMATION SHEET INSTITUTION HEADED PAPER 1. Study title Treatment Intensities and Targets in Rheumatoid Arthritis Therapy (the TITRATE trial). 2. Key Facts TITRATE is a trial for patients with

More information

Basal Cell Carcinoma Affecting the Eye Your Treatment Explained

Basal Cell Carcinoma Affecting the Eye Your Treatment Explained Basal Cell Carcinoma Affecting the Eye Your Treatment Explained Patient Information Introduction This booklet is designed to give you information about having a Basal Cell Carcinoma near your eye and the

More information

Establishing Your Diagnosis Lung Investigations Explained

Establishing Your Diagnosis Lung Investigations Explained Establishing Your Diagnosis Lung Investigations Explained Patient Information Introduction This leaflet tells you about tests that may be performed to investigate the cause of your chest symptoms or the

More information

3. Diagnosing Lung Cancer

3. Diagnosing Lung Cancer Lung cancer is a difficult disease to diagnose and there is no routine screening in Australia for its early detection. For some people, lung cancer is discovered during a routine medical check-up, while

More information

Participant Information Sheet (Version 6, )

Participant Information Sheet (Version 6, ) Participant Information Sheet (Version 6, 10.11.15) Research study to determine the genetic causes of Primary Sclerosing Cholangitis Dear patient, We would like to invite you to take part in the UK PSC

More information

Abdominal aortic aneurysm screening: A decision for men aged 65 or over

Abdominal aortic aneurysm screening: A decision for men aged 65 or over Abdominal Aortic Aneurysm Abdominal aortic screening: A decision for men aged 65 or over Screening is a choice. Men aged 65 and over have the following choice: Get screened for abdominal aortic or Do not

More information

100,000 Genomes Project. Participant Information Sheet. For families of patients with rare genetic diseases. About the 100,000 Genomes Project

100,000 Genomes Project. Participant Information Sheet. For families of patients with rare genetic diseases. About the 100,000 Genomes Project 100,000 Genomes Project Insert hospital logo here Participant Information Sheet This sheet summarises the project and key points that you need to consider regarding your potential participation in this

More information

MOHS MICROGRAPHIC SURGERY

MOHS MICROGRAPHIC SURGERY MOHS MICROGRAPHIC SURGERY What are the aims of this leaflet? This leaflet has been written to help you understand more about Mohs micrographic surgery. It tells you what it is, what is involved and what

More information

Questions to Ask As You Learn More About Kidney Cancer

Questions to Ask As You Learn More About Kidney Cancer Questions to Ask As You Learn More About Kidney Cancer Now that you have been diagnosed with kidney cancer, it is important for you to understand your condition and your treatment options. Many patients

More information

Liver Surveillance Service

Liver Surveillance Service The Clatterbridge Cancer Centre NHS Foundation Trust Liver Surveillance Service General information A guide for patients and carers Contents About the liver surveillance service... 2 About the MRI Scan...

More information

Lymphoma diagnosis and staging

Lymphoma diagnosis and staging Produced 28.02.2011 Revision due 28.02.2013 Lymphoma diagnosis and staging The word diagnosis means finding out what is wrong. This document describes: how lymphoma is diagnosed the tests you will have

More information

Radiotherapy Local radiotherapy for rectal cancer (Papillon)

Radiotherapy Local radiotherapy for rectal cancer (Papillon) Radiotherapy Local radiotherapy for rectal cancer (Papillon) Clatterbridge Centre for Oncology NHS Foundation Trust This information is for patients who have cancer of the rectum (back passage) and who

More information

Yes - Men get Breast Cancer too

Yes - Men get Breast Cancer too Yes - Men get Breast Cancer too Exceptional healthcare, personally delivered Introduction Breast cancer is a rare condition in men. Approximately 300 cases are diagnosed every year in the United Kingdom

More information

Endoscopic axillary lymph node retrieval for breast cancer

Endoscopic axillary lymph node retrieval for breast cancer Issue date: December 2005 Endoscopic axillary lymph node retrieval for Understanding NICE guidance information for people considering the procedure, and for the public Information about NICE Interventional

More information

This information explains the advice about prostate cancer that is set out in NICE clinical guideline 175.

This information explains the advice about prostate cancer that is set out in NICE clinical guideline 175. Information for the public Published: 1 January 2014 nice.org.uk About this information NICE clinical guidelines advise the NHS on caring for people with specific conditions or diseases and the treatments

More information

Having a bone biopsy in the interventional radiology department

Having a bone biopsy in the interventional radiology department Having a bone biopsy in the interventional radiology department This information sheet has been given to you to help answer some of the questions you may have about having a bone biopsy. If you have any

More information

Primary bone cancer. For people with cancer, their family and friends

Primary bone cancer. For people with cancer, their family and friends This fact sheet is for people with primary bone cancer who would like to know more about their cancer and its treatment. It describes the types, causes and symptoms of primary bone cancer, as well as treatments

More information

Having a renal (kidney) biopsy in the interventional radiology department

Having a renal (kidney) biopsy in the interventional radiology department Having a renal (kidney) biopsy in the interventional radiology department This information sheet has been given to you to help answer some of the questions you may have about having a renal (kidney) biopsy.

More information

PATIENT INFORMATION SHEET (PIS2) (Consent step 2)

PATIENT INFORMATION SHEET (PIS2) (Consent step 2) PATIENT INFORMATION SHEET FOR FOCUS4-N (PIS2-N) PATIENT INFORMATION SHEET (PIS2) (Consent step 2) Date: Version 1.0, February 2013 FOCUS4 Information for patients who are

More information

Sentinel Lymph Node Biopsy: An Information Guide for Patients

Sentinel Lymph Node Biopsy: An Information Guide for Patients Sentinel Lymph Node Biopsy: An Information Guide for Patients Disclaimer This is general information developed by The Ottawa Hospital. It is not intended to replace the advice of a qualified healthcare

More information

Lymph Node Dissection for Penile Cancer

Lymph Node Dissection for Penile Cancer Lymph Node Dissection for Penile Cancer Exceptional healthcare, personally delivered Removal of Lymph Nodes Why are the Lymph Nodes so important when I have penile cancer? Lymph nodes are small bean shaped

More information

Genetic Variation in Adults with Learning Disability: Participant Information Sheet

Genetic Variation in Adults with Learning Disability: Participant Information Sheet Version 3, 15th January 2012 UCL MENTAL HEALTH SCIENCES UNIT FACULTY OF BRAIN SCIENCES BLOOMSBURY CAMPUS Genetic Variation in Adults with Learning Disability: Participant Information Sheet Part 1 We would

More information

How testicular cancer is diagnosed

How testicular cancer is diagnosed How testicular cancer is diagnosed This information is from the booklet Understanding testicular cancer. You may find the full booklet helpful. We can send you a free copy see page 6. Contents What happens

More information

Subject Information and Consent Form

Subject Information and Consent Form Subject Information and Consent Form 18 F-Sodium Fluoride Positron Emission Tomography / Computed Tomography ( 18 F-NaF PET/CT) Imaging as a Replacement for 99m Technetium Bone Scintigraphy BCCA Principal

More information

Having surgery for DCIS

Having surgery for DCIS This information is an extract from the booklet Understanding ductal carcinoma in situ (DCIS). You may find the full booklet helpful. We can send you a free copy see page 6. Contents Before your operation

More information

FAQs for Participants

FAQs for Participants FAQs for Participants What are clinical trials? What are the different types of clinical trials? What is a protocol? What is an IRB? Where can I find information about current clinical trials? How can

More information

What to expect from your doctor when you have a cosmetic procedure

What to expect from your doctor when you have a cosmetic procedure What to expect from your doctor when you have a cosmetic procedure Medical Council of New Zealand This guide outlines what to expect when you see a doctor for a cosmetic procedure. It does not cover cosmetic

More information

OHSU Knight Cancer Institute Research Repository Consent Form

OHSU Knight Cancer Institute Research Repository Consent Form OHSU Knight BioLibrary IRB# 4918 PI: Kelly OHSU Knight Cancer Institute Research Repository Consent Form REPOSITORY TITLE: OHSU BioLibrary PRINCIPAL INVESTIGATOR: Devon Kelly, MS (503) 494-9431 PHYSICIAN

More information

Is It Lung Cancer? Patient Pathway. Initial Presentation & Imaging. Diagnostic Tests STEP 1 STEP 2 STEP 3 STEP 4

Is It Lung Cancer? Patient Pathway. Initial Presentation & Imaging. Diagnostic Tests STEP 1 STEP 2 STEP 3 STEP 4 Patient Pathway Is It Lung Cancer? A pathway map of your lung cancer diagnosis journey A Patient Pathway is a way for you to learn about your journey and what to expect as you move through the health care

More information

RESEARCH SUBJECT INFORMATION AND CONSENT FORM

RESEARCH SUBJECT INFORMATION AND CONSENT FORM 1 1 1 1 1 1 1 0 1 0 1 0 RESEARCH SUBJECT INFORMATION AND CONSENT FORM TITLE: PROTOCOL NR: SPONSOR: INVESTIGATOR: WIRB VCU tracking number This template is based on a drug or device research study. The

More information

Collection of Nervous System Tissue and/or Blood for Future Research Use BRASH - Brain Tissue Bank South West

Collection of Nervous System Tissue and/or Blood for Future Research Use BRASH - Brain Tissue Bank South West Collection of Nervous System Tissue and/or Blood for Future Research Use BRASH - Brain Tissue Bank South West Exceptional healthcare, personally delivered We would like to invite you to take part in our

More information

Ultrasound guided liver biopsy

Ultrasound guided liver biopsy Oxford University Hospitals NHS Trust Ultrasound guided liver biopsy Information for patients Please bring this booklet and signed consent form with you page 2 Your appointment You will be having the liver

More information

PARTICIPANT INFORMATION SHEET FEASIBILITY TRIAL Final Version 1.1:

PARTICIPANT INFORMATION SHEET FEASIBILITY TRIAL Final Version 1.1: PARTICIPANT INFORMATION SHEET FEASIBILITY TRIAL Final Version 1.1: 10.10.13 Title of Study: FRESH: Facilitating Return to work through Early Specialist Health-based interventions. (Working After Brain

More information

100,000 Genomes Project West Midlands NHS Genomic Medicine Centre

100,000 Genomes Project West Midlands NHS Genomic Medicine Centre england 100,000 Genomes Project West Midlands NHS Genomic Medicine Centre not you want to take part. If you don t want to take part in this Project, you don t have to. You don t have to give a 1. INTRODUCTION

More information

Cancer and Clinical Trials

Cancer and Clinical Trials Treatment Cancer and Clinical Trials Cancer and Clinical Trials This factsheet aims to help you to understand more about clinical trials. We hope that it answers some of your questions about clinical trials,

More information

Treating intractable chronic migraine by stimulating nerves at the back of the head

Treating intractable chronic migraine by stimulating nerves at the back of the head Issue date April 2013 Information for the public NICE interventional procedures guidance advises the NHS on when and how new procedures can be used in clinical practice. Treating intractable chronic migraine

More information

What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide

What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide A M E R I C A N C O L L E G E O F C H E S T P H Y S I C I A N S Lung cancer is one of the most common cancers. About 170,000

More information

A Guide to Clinical Trials

A Guide to Clinical Trials A Guide to Clinical Trials For young people with cancer and their parents Children s Cancer and Leukaemia Group www.cclg.org.uk Original booklet produced in conjunction with the CCLG Patient Advocacy Committee.

More information

Understanding clinical trials

Understanding clinical trials Understanding clinical trials 3 Contents Introduction 4 What are clinical trials? 5 Why are clinical trials important? How are trials set up? Who can take part in clinical trials? How are people asked

More information

IS RFA THE RIGHT OPTION FOR ME?

IS RFA THE RIGHT OPTION FOR ME? IS RFA THE RIGHT OPTION FOR ME? RadioFrequency Ablation (RFA) is the preferred treatment when tumors are small, unreachable, or cannot be removed surgically. RFA is particularly beneficial for patients

More information

Information for patients having Sentinel Lymph Node Biopsy (SLNB)

Information for patients having Sentinel Lymph Node Biopsy (SLNB) Oxford University Hospitals NHS Trust Information for patients having Sentinel Lymph Node Biopsy (SLNB) The aim of this booklet is to give you some general information about your surgery. If you have any

More information

Catheter insertion of a new aortic valve to treat aortic stenosis

Catheter insertion of a new aortic valve to treat aortic stenosis Issue date March 2012 Understanding NICE guidance Information for people who use NHS services NICE interventional procedures guidance advises the NHS on when and how new procedures can be used in clinical

More information

Interstitial laser therapy for fibroadenomas of the breast

Interstitial laser therapy for fibroadenomas of the breast Issue date: June 2005 Interstitial laser therapy for fibroadenomas of Understanding NICE guidance information for people considering the procedure, and for the public Information about NICE Interventional

More information

Breast care clinics. The Breast Clinics take place every week on Wednesdays. yeovilhospital.nhs.uk

Breast care clinics. The Breast Clinics take place every week on Wednesdays. yeovilhospital.nhs.uk Breast care clinics The Breast Clinics take place every week on Wednesdays 01935 384 352 yeovilhospital.nhs.uk Yeovil District Hospital NHS Foundation Trust has a specialist Breast Care Team. This team

More information

Laparoscopy and Associated Treatment in Adolescence. An information leaflet for patients, parents and guardians

Laparoscopy and Associated Treatment in Adolescence. An information leaflet for patients, parents and guardians Laparoscopy and Associated Treatment in Adolescence An information leaflet for patients, parents and guardians 1 Contents 1. Introduction 2. What is laparoscopy? 3. How is it done? 4. What tests are carried

More information

Ductal carcinoma in situ (DCIS)

Ductal carcinoma in situ (DCIS) DIAGNOSIS: DCIS Ductal carcinoma in situ (DCIS) This factsheet gives information on an early form of breast cancer called ductal carcinoma in situ (DCIS). It explains what it is, how your breast is made

More information

Your visit to the Breast Clinic. Information for patients Breast Services

Your visit to the Breast Clinic. Information for patients Breast Services Your visit to the Breast Clinic Information for patients Breast Services This leaflet will provide you with information about the Breast Clinic and what might happen during your appointment. If after reading

More information

Soft tissue sarcoma. For people with cancer, their family and friends

Soft tissue sarcoma. For people with cancer, their family and friends This fact sheet is for people with soft tissue sarcoma who would like to know more about their cancer and its treatment. It describes the types, causes and symptoms of soft tissue sarcoma as well as treatments

More information

Oncology Service. What is Cancer of Unknown Primary (CUP)?

Oncology Service. What is Cancer of Unknown Primary (CUP)? Oncology Service What is Cancer of Unknown Primary (CUP)? 2 What is cancer of unknown primary (CUP)? CUP is a general term that covers many different types of cancer. It affects about 3-5% of people with

More information

PARTICIPANT INFORMATION SHEET A randomised trial of krill oil for osteoarthritis of the knee

PARTICIPANT INFORMATION SHEET A randomised trial of krill oil for osteoarthritis of the knee PARTICIPANT INFORMATION SHEET A randomised trial of krill oil for osteoarthritis of the knee 1. Invitation You are invited to participate in a research study investigating an experimental treatment for

More information

Ultrasound Guided Liver Biopsy

Ultrasound Guided Liver Biopsy Ultrasound Guided Liver Biopsy Patient Information Author ID: N Prasad and G Banait Leaflet Number: End 006 Name of Leaflet: Ultrasound Guided Liver Biopsy Date Produced: March 2014 Review Date: March

More information

BOWEL CANCER. The doctor has explained that you have a growth or tumour, in your bowel or rectum and could be cancer.

BOWEL CANCER. The doctor has explained that you have a growth or tumour, in your bowel or rectum and could be cancer. Patient and Carer Information BOWEL CANCER Please read this leaflet carefully. It is important that you take note of any instructions or advice given. If you have any questions or problems that are not

More information

PARENT CONSENT FORM ORAL INSULIN STUDY

PARENT CONSENT FORM ORAL INSULIN STUDY PARENT CONSENT FORM ORAL INSULIN STUDY TITLE: SPONSOR INVESTIGATORS: Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus TrialNet (funded by The National Institutes

More information

Inflammatory breast cancer

Inflammatory breast cancer april 2007 information about Inflammatory breast cancer What is inflammatory breast cancer? Inflammatory breast cancer is a rare and rapidly growing form of breast cancer. Unlike other breast cancers which

More information

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic. bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.

More information

PROCEDURE- SPECIFIC INFORMATION FOR PATIENTS

PROCEDURE- SPECIFIC INFORMATION FOR PATIENTS The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E- mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk PROCEDURE-

More information

SQUAMOUS CELL CARCINOMA

SQUAMOUS CELL CARCINOMA SQUAMOUS CELL CARCINOMA What are the aims of this leaflet? This leaflet has been written to help you understand more about squamous cell carcinomas of the skin. It tells you what they are, what causes

More information

Surgical repair of anal fistula with a bioprosthetic plug

Surgical repair of anal fistula with a bioprosthetic plug Issue date November 2011 Understanding NICE guidance Information for people who use NHS services Surgical repair of anal fistula with a bioprosthetic plug NICE interventional procedures guidance advises

More information

PROCEDURE- SPECIFIC INFORMATION FOR PATIENTS

PROCEDURE- SPECIFIC INFORMATION FOR PATIENTS The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E- mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk PROCEDURE-

More information